Giese NA - Search Results

1

Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer.

Zhang Y, Liu L, Fan P, Bauer N, Gladkich J, Ryschich E, Bazhin AV, Giese NA, Strobel O, Hackert T, Hinz U, Gross W, Fortunato F, Herr I. Zhang Y, et al. Among authors: giese na. Oncotarget. 2015 Apr 30;6(12):9999-10015. doi: 10.18632/oncotarget.3171. Oncotarget. 2015. PMID: 25846752 Free PMC article.

2

Effects of STI571 (gleevec) on pancreatic cancer cell growth.

Li J, Kleeff J, Guo J, Fischer L, Giese N, Büchler MW, Friess H. Li J, et al. Mol Cancer. 2003 Sep 17;2:32. doi: 10.1186/1476-4598-2-32. Mol Cancer. 2003. PMID: 14521721 Free PMC article.

3

Gefitinib ('Iressa', ZD1839), a selective epidermal growth factor receptor tyrosine kinase inhibitor, inhibits pancreatic cancer cell growth, invasion, and colony formation.

Li J, Kleeff J, Giese N, Büchler MW, Korc M, Friess H. Li J, et al. Int J Oncol. 2004 Jul;25(1):203-10. Int J Oncol. 2004. PMID: 15202007

4

Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action.

Köninger J, Giese NA, di Mola FF, Berberat P, Giese T, Esposito I, Bachem MG, Büchler MW, Friess H. Köninger J, et al. Among authors: giese t, giese na. Clin Cancer Res. 2004 Jul 15;10(14):4776-83. doi: 10.1158/1078-0432.CCR-1190-03. Clin Cancer Res. 2004. PMID: 15269152

5

Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment.

Berberat PO, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Künzli B, Autschbach F, Meuer S, Büchler MW, Friess H. Berberat PO, et al. Clin Cancer Res. 2005 May 15;11(10):3790-8. doi: 10.1158/1078-0432.CCR-04-2159. Clin Cancer Res. 2005. PMID: 15897578

6

The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis.

Ceyhan GO, Bergmann F, Kadihasanoglu M, Erkan M, Park W, Hinz U, Giese T, Müller MW, Büchler MW, Giese NA, Friess H. Ceyhan GO, et al. Among authors: giese t, giese na. Gut. 2007 Apr;56(4):534-44. doi: 10.1136/gut.2006.105528. Epub 2006 Oct 17. Gut. 2007. PMID: 17047099 Free PMC article.

7

Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer.

Müller MW, Giese NA, Swiercz JM, Ceyhan GO, Esposito I, Hinz U, Büchler P, Giese T, Büchler MW, Offermanns S, Friess H. Müller MW, et al. Among authors: giese t, giese na. Int J Cancer. 2007 Dec 1;121(11):2421-33. doi: 10.1002/ijc.22949. Int J Cancer. 2007. PMID: 17631638

8

PKC 412 small-molecule tyrosine kinase inhibitor: single-compound therapy for pancreatic cancer.

El Fitori J, Su Y, Büchler P, Ludwig R, Giese NA, Büchler MW, Quentmeier H, Hines OJ, Herr I, Friess H. El Fitori J, et al. Among authors: giese na. Cancer. 2007 Oct 1;110(7):1457-68. doi: 10.1002/cncr.22931. Cancer. 2007. PMID: 17676584 Free article.

9

CXCL14 expression and potential function in pancreatic cancer.

Wente MN, Mayer C, Gaida MM, Michalski CW, Giese T, Bergmann F, Giese NA, Büchler MW, Friess H. Wente MN, et al. Among authors: giese t, giese na. Cancer Lett. 2008 Feb 8;259(2):209-17. doi: 10.1016/j.canlet.2007.10.021. Epub 2007 Nov 28. Cancer Lett. 2008. PMID: 18054154

10

Uroguanylin inhibits proliferation of pancreatic cancer cells.

Kloeters O, Friess H, Giese N, Buechler MW, Cetin Y, Kulaksiz H. Kloeters O, et al. Scand J Gastroenterol. 2008;43(4):447-55. doi: 10.1080/00365520701746378. Scand J Gastroenterol. 2008. PMID: 18365910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters